Publication Name	World Journal of Gastroenterology
Manuscript ID	9439
Country	China

Received	2014-02-19 10:49
Peer-Review Started	2014-02-20 14:50
To Make the First Decision	2014-03-13 18:51
Return for Revision	2014-03-23 15:46
Revised	2014-04-16 23:08
Second Decision	2014-06-26 16:56
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-06-26 17:31
Articles in Press	2014-06-26 17:59
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-07-27 21:33
Typeset the Manuscript	2014-09-25 11:20
Publish the Manuscript Online	2014-10-16 15:53

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Clinical Trials Study
Article Title	S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer
Manuscript Source	Unsolicited Manuscript
All Author List	Qing-Hua Ke, Shi-Qiong Zhou, Ji-Yuan Yang, Wei Du, Gai Liang, Yong Lei and Fei Luo
Funding Agency and Grant Number
Corresponding Author	Ji-Yuan Yang, Professor, Department of Chemoradiotherapy, Oncology Hospital of Jingzhou, No. 40 Jinglong Road, Shashi District, Jingzhou 434000, Hubei Province, China. yangjiyuancn@yeah.net
Key Words	Chemoradiotherapy; Radiosensitizer; S-1; Pancreatic cancer; CA19-9
Core Tip	The article describes a study of the combination of S-1 with gemcitabine S-1 followed by oral S-1 with concurrent radiotherapy and maintenance therapy with S-1 for locally advanced pancreatic cancer. It is considered a well-tolerated, promising and effective treatment for unresectable advanced pancreatic cancer.
Publish Date	2014-10-16 15:53
Citation	Ke QH, Zhou SQ, Yang JY, Du W, Liang G, Lei Y, Luo F. S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer. World J Gastroenterol 2014; 20(38): 13987-13992
URL	http://www.wjgnet.com/1007-9327/full/v20/i38/13987.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i38.13987

Full Article (PDF)	WJG-20-13987.pdf
Full Article (Word)	WJG-20-13987.doc
Manuscript File	9439-Review.docx
Answering Reviewers	9439-Answering reviewers.pdf
Copyright License Agreement	9439-Copyright assignment.pdf
Peer-review Report	9439-Peer review(s).pdf
Scientific Misconduct Check	9439-CrossCheck.jpg
Scientific Editor Work List	9439-Scientific editor work list.pdf